Article
Radiogenomics-based Risk Prediction of Glioblastoma Multiforme with Clinical Relevance
2018-06-20
Abstract excerpt
GBM is the most common and aggressive primary brain tumor. Although the TMZ-based radiochemotherapy improves overall GBM patients’ survival, it also increases the frequency of false positive post-treatment magnetic resonance imaging (MRI) assessments for tumor progression. Pseudoprogression is a treatment-related reaction with an increase in contrast-enhancing lesion size at the tumor site or resection margins whi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7623df46-3eb5-56d9-92c0-5eadf1db9ce6
- DOI
- 10.1101/350934
